Global Biopsy Devices - Analysis and Market Forecasts; New Report Launched
The biopsy devices space across the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, China, and India, will rise modestly in value from $915.2 million to over $1.16 billion by 2022, at a CAGR of 3.5%. Emerging countries in the Asia-Pacific region, such as India and China, will have growth rates similar to the global CAGR due to increased market access of each country's population to healthcare resources. Although the market value is rising, there are several barriers preventing...
View full press release